Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 178-184

  Kiyokawa, Nobutaka ^a   Taguchi, Tomoko ^a   Mori, Tetsuya ^a   Uchida, Hiroshi ^a   Sato, Norihide ^a   Takeda, Tae ^a   Fujimoto, Junichiro ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; DNA FRAGMENT; ESCHERICHIA COLI ENDOTOXIN; GLOBOTRIAOSYLCERAMIDE; MEMBRANE ANTIGEN; SHIGA TOXIN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BINDING AFFINITY; CYTOTOXICITY; ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; KIDNEY TUBULE CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0031846424     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515592     Document Type: Article

References (15)

1. Karmali MA, Petric M, Lim C, Fleming DC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin producing Escherichia coli. J Infect Dis 1985;151: 775-82.
2. Fong JS, De Chadarevian JP, Kaplan BS. Hemolytic uremic syndrome. Current concepts and management. Pediatr Clin North Am 1982;29: 835-56.
3. Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988;19:1102-8.
4. Obrig TG, Del-Vecchio PJ, Brown JE, et al. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 1988; 56:2373-8.
5. Tesh VL, Samuel JE, Perera LP, Sharefkin JB, O'Brien AD. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 1991;164:344-52.
6. Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1β enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun 1993;61:3886-91.
7. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993;268:15484-8.
8. Kaplan BS, Cleary TG, Obrig TG. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol 1990; 4:276-83.
9. Arends MJ, Harrison DJ. Novel histopathologic findings in a surviving case of hemolytic uremic syndrome after bone marrow transplantation. Hum Pathol 1989;20:89-91.
10. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 1996;87:3245-54.
11. Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 1997;89:1224-34.
12. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 1990; 58:3959-65.
13. Lindgren SW, Melton AR, O'Brien AD. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 1993;61:3832-42.
14. Tesh VL, Burris JA, Owens JW, et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 1993; 61:3392-402.
15. Oosterwijk E, Kalisiak A, Wakka JC, Scheinberg DA, Old LJ. Monoclonal antibodies against Galα1-4Ga1β1-4Glc(Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors. Int J Cancer 1991;48:848-54.